期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity:Hope from natural mitochondrial nutrients 被引量:24
1
作者 Jiankang Liu Institute of Mitochondrial Biology and Medicine, Xi’an Jiaotong University School of Life Science and Technology, Xi’an 710049, China 《生物物理学报》 CAS CSCD 北大核心 2009年第S1期100-100,共1页
Insulin resistance is an important feature of type 2 diabetes and obesity. The underlying mechanisms of insulin resistance are still unclear. Mitochondrial dysfunction,
关键词 Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity
原文传递
Morbid Obesity in Diabetes Mellitus Type 2 and Exenatide
2
作者 Maria Angeles Ibanez Gil Alfonso Lopez Ruiz +3 位作者 Alicia Hernandez Torres Ana Belen Hernandez Cascales Pedro Pujante Alarcon Maria Dolores Hellin Gil 《Pharmacology & Pharmacy》 2014年第2期149-152,共4页
Worldwide, the prevalence of diabetes and obesity is increasing in recent years in developed countries. The first step of treatment is changes in lifestyle and in case of failure to initiate drug treatment. In our cas... Worldwide, the prevalence of diabetes and obesity is increasing in recent years in developed countries. The first step of treatment is changes in lifestyle and in case of failure to initiate drug treatment. In our case, the patient with morbid obesity and glucose intolerance to metformin therapy was initiated without achieving weight loss and loss of glycemic control after 6 months of treatment. It was decided to add exenatide as an alternative to bariatric surgery. At the end of the study (12 months), it showed a weight reduction of 20.8% (Table 1), 20.83% BMI, glycosylated hemoglobin decrease of 2 points, and improved the lipid profile. So exenatide may be an acceptable option in the use of patient profile. It would be necessary to seek a new alternative treatment with minimal side effects and less healthcare costs. 展开更多
关键词 Type 2 diabetes and obesity EXENATIDE
下载PDF
Association of TCF7L2 and GCG Gene Variants with Insulin Secretion,Insulin Resistance,and Obesity in New-onset Diabetes 被引量:1
3
作者 ZHANG Lu ZHANG Ming +13 位作者 WANG Jin Jin WANG Chong Jian REN Yong Cheng WANG Bing Yuan ZHANG Hong Yan YANG Xiang Yu ZHAO Yang HAN Cheng Yi ZHOU Jun Mei PANG Chao YIN Lei ZHAO Jing Zhi LUO Xin Ping HU Dong Sheng 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2016年第11期814-817,共4页
This cohort study was designed to evaluate the association of transcription factor 7-like 2 (TCF7L2) and proglucagon gene (GCG) variants with disordered glucose metabolism and the incidence of type 2 diabetes mell... This cohort study was designed to evaluate the association of transcription factor 7-like 2 (TCF7L2) and proglucagon gene (GCG) variants with disordered glucose metabolism and the incidence of type 2 diabetes mellitus (T2DM) in a rural adult Chinese population. A total of 7,751 non-T2DM participants 〉18 years old genotyped at baseline were recruited. The same questionnaire interview and physical and blood biochemical examinations were performed at both baseline and follow-up. During a median 6 years of follow-up, T2DM developed in 227 participants. After adjustment for potential contributory factors, nominally significant associations were seen between 3T genotype and the recessive model of TCFTI.2 rs7903146 and increased risk of T2DM [hazard ratio (HR)=4.068, 95% confidence interval (CI): 1.270-13.026; HR=4.051, 95% CI: 1.268-12.946, respectively]. The TT genotype of rs7903146 was also significantly associated with higher fasting plasma insulin level and the homeostasis model assessment of insulin resistance in case of new-onset diabetes. In addition, the TCF7L2 rs290487 TT genotype was associated with abdominal obesity and the GCG rs12104705 CC genotype was associated with both general obesity and abdominal obesity in case of new-onset diabetes. 展开更多
关键词 TCF GCG Insulin Resistance and obesity in New-onset diabetes
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部